Keyron Medical
Founded 2016 · 8 employees on LinkedIn · 2 known investors
Find your way into Keyron Medical
Sign up to see every warm intro you have to Keyron Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Keyron Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.
Founders & leadership
Keyron Medical was founded in 2016 by Giorgio Castagneto Gissey.






Board
Investors · 2
How we know: Health Wildcatters's portfolio page · a partner's Signal profile · Not right? Tell us
Related companies · 1
Companies working in the same space as Keyron Medical.
In the news
Frequently asked questions
- What does Keyron Medical do?
- Keyron develops ForePass, a fully endoscopic, non-invasive and reversible gastric bypass medical device intended to reproduce the effects of metabolic surgery for patients with Class II & III obesity, type 2 diabetes, MASH/NASH, and liver fibrosis. The company targets severe "diabesity" patients who refuse surgery or do not achieve results with drugs, across the US and EU5 markets.
- Who founded Keyron Medical?
- Keyron Medical was founded by Giorgio Castagneto Gissey in 2016.
- Who are Keyron Medical's investors?
- Keyron Medical's investors include Health Wildcatters, Riceberg Ventures Premier.


